UnitedHealth Group (NYSE:UNH) Shares Gap Up Following Analyst Upgrade

Key Points

• UnitedHealth shares gapped up premarket after Sanford C. Bernstein raised its price target from $405 to $411 and kept an outperform rating; the stock opened at $308.85 after a $281.36 close.
• The CMS finalized a 2.48% boost to 2027 Medicare Advantage payment rates (about $13B), which eased margin concerns and prompted bullish analyst reactions and stronger trading in health-insurer names.
• Near-term risks remain: UNH must validate margin recovery with its Q1 results (April 21), and technical/valuation headwinds persist as the stock trades below its 200‑day moving average, potentially limiting upside.

UnitedHealth Group Incorporated (NYSE:UNH - Get Free Report) shares gapped up before the market opened on Tuesday after Sanford C. Bernstein raised their price target on the stock from $405.00 to $411.00. The stock had previously closed at $281.36, but opened at $308.85. Sanford C. Bernstein currently has an outperform rating on the stock. UnitedHealth Group shares last traded at $304.0070, with a volume of 6,970,907 shares traded.

UNH has been the topic of several other reports. Weiss Ratings cut shares of UnitedHealth Group from a "hold (c-)" rating to a "sell (d+)" rating in a report on Monday, March 2nd. Leerink Partners lowered their target price on shares of UnitedHealth Group from $410.00 to $345.00 and set an "outperform" rating on the stock in a report on Wednesday, January 28th. Royal Bank Of Canada reduced their price target on shares of UnitedHealth Group from $408.00 to $361.00 and set an "outperform" rating on the stock in a research report on Wednesday, January 28th. Morgan Stanley reduced their price target on shares of UnitedHealth Group from $411.00 to $409.00 and set an "overweight" rating on the stock in a research report on Friday, January 23rd. Finally, Piper Sandler reiterated an "overweight" rating on shares of UnitedHealth Group in a research report on Tuesday, January 27th. One investment analyst has rated the stock with a Strong Buy rating, eighteen have issued a Buy rating, eight have assigned a Hold rating and two have assigned a Sell rating to the stock. According to data from MarketBeat, UnitedHealth Group presently has a consensus rating of "Moderate Buy" and an average price target of $363.42.

Trending Headlines about UnitedHealth Group

Here are the key news stories impacting UnitedHealth Group this week:

• Positive Sentiment: CMS finalizes a 2.48% boost to 2027 Medicare Advantage payment rates, which injects roughly $13B into the MA program and removes a key margin overhang for large MA players like UnitedHealth. Trump administration finalizes better-than-feared Medicare Advantage payment rate
• Positive Sentiment: Health-insurer stocks reacted strongly in premarket/after-hours trading on the CMS decision, lifting UnitedHealth sentiment and trading activity. Health insurers rise after US lifts 2027 Medicare Advantage payment rates
• Positive Sentiment: Buy-side/independent analysts have turned more constructive: Seeking Alpha argues the CMS move materially reduces margin risk and supports a bullish repricing, and Raymond James upgraded UNH ahead of Q1. UnitedHealth: The CMS Boost Changes Everything Now Raymond James boosts UnitedHealth
• Neutral Sentiment: HSBC changed its rating from "reduce" to "hold" with a $300 price target — a modest positive signal but not an aggressive upgrade; it implies limited near-term upside from that shop.
• Neutral Sentiment: UNH is getting listed in "stocks to watch" and broad coverage across outlets as the policy and analyst mix creates a market narrative shift. Stocks to Watch: UnitedHealth, Humana, Universal Music Group, Broadcom
• Negative Sentiment: Q1 results (scheduled April 21) remain a near-term catalyst and risk — management must validate margin recovery, and prior guidance/soft results contributed to the recent selloff. Is April 21 When UnitedHealth Group Finally Sheds Its Problem Past?
• Negative Sentiment: Technical/valuation headwinds remain: UNH trades below its 200-day moving average and well under its 12‑month high, reflecting material investor skepticism that could limit near-term upside absent sustained positive execution.

Institutional Trading of UnitedHealth Group

A number of hedge funds have recently added to or reduced their stakes in the stock. North Capital Inc. boosted its position in UnitedHealth Group by 16.2% in the third quarter. North Capital Inc. now owns 194 shares of the healthcare conglomerate's stock valued at $67,000 after buying an additional 27 shares in the last quarter. Sunflower Bank N.A. boosted its position in UnitedHealth Group by 1.5% in the third quarter. Sunflower Bank N.A. now owns 1,916 shares of the healthcare conglomerate's stock valued at $662,000 after buying an additional 28 shares in the last quarter. Axis Wealth Partners LLC raised its stake in shares of UnitedHealth Group by 1.7% during the third quarter. Axis Wealth Partners LLC now owns 1,631 shares of the healthcare conglomerate's stock valued at $563,000 after acquiring an additional 28 shares during the last quarter. Abound Wealth Management raised its stake in shares of UnitedHealth Group by 13.5% during the third quarter. Abound Wealth Management now owns 244 shares of the healthcare conglomerate's stock valued at $84,000 after acquiring an additional 29 shares during the last quarter. Finally, Founders Capital Management LLC raised its stake in shares of UnitedHealth Group by 3.0% during the fourth quarter. Founders Capital Management LLC now owns 982 shares of the healthcare conglomerate's stock valued at $324,000 after acquiring an additional 29 shares during the last quarter. Institutional investors and hedge funds own 87.86% of the company's stock.

UnitedHealth Group Price Performance

The company's 50 day moving average price is $281.61 and its 200-day moving average price is $319.24. The stock has a market cap of $275.82 billion, a P/E ratio of 23.08, a P/E/G ratio of 1.28 and a beta of 0.40. The company has a quick ratio of 0.79, a current ratio of 0.79 and a debt-to-equity ratio of 0.72.

UnitedHealth Group (NYSE:UNH - Get Free Report) last released its quarterly earnings results on Tuesday, January 27th. The healthcare conglomerate reported $2.11 earnings per share (EPS) for the quarter, beating the consensus estimate of $2.09 by $0.02. The firm had revenue of $113.73 billion during the quarter, compared to the consensus estimate of $113.38 billion. UnitedHealth Group had a net margin of 2.69% and a return on equity of 14.79%. The company's revenue for the quarter was up 12.3% on a year-over-year basis. During the same quarter last year, the firm earned $6.81 earnings per share. UnitedHealth Group has set its FY 2026 guidance at 17.750- EPS. As a group, sell-side analysts expect that UnitedHealth Group Incorporated will post 29.54 earnings per share for the current year.

UnitedHealth Group Dividend Announcement

The company also recently announced a quarterly dividend, which was paid on Tuesday, March 17th. Investors of record on Monday, March 9th were paid a dividend of $2.21 per share. This represents a $8.84 dividend on an annualized basis and a yield of 2.9%. The ex-dividend date of this dividend was Monday, March 9th. UnitedHealth Group's dividend payout ratio (DPR) is currently 67.02%.

About UnitedHealth Group

UnitedHealth Group Inc is a diversified health care company headquartered in Minnetonka, Minnesota, that operates two primary business platforms: UnitedHealthcare and Optum. Founded in 1977, the company provides a broad range of health benefits and health care services to individuals, employers, governmental entities and other organizations. Its operations span commercial employer-sponsored plans, individual and Medicare and Medicaid programs, and services for customers and health systems in the United States and selected international markets.

UnitedHealthcare is the company's benefits business, administering health plans and networks, managing provider relationships, and offering coverage products for employers, individuals, and government-sponsored programs.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.